Non-invasive Predictors of Esophageal Varices and Their Correlation to Upper Endoscopic Findings
1 other identifier
observational
51
0 countries
N/A
Brief Summary
The goal of this observational study:
- To evaluate the diagnostic accuracy of non-invasive markers in predicting the presence and grading of esophageal varices in children with portal hypertension.
- To correlate these non-invasive markers with the severity of portal hypertension and the grade of esophageal varices to identify patients at high risk of bleeding.
- To propose a defined protocol for screening esophageal varices in those children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 11, 2026
CompletedStudy Start
First participant enrolled
March 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 20, 2028
March 23, 2026
March 1, 2026
2 years
March 2, 2026
March 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Area Under the Receiver Operating Characteristic (AUROC) Curve of non-invasive markers for predicting esophageal varices in children with portal hypertension
The AUROC will be used as the aggregate reported value to represent the diagnostic performance of the following markers: platelet count, spleen size z-score, platelet-to-spleen ratio, AST-to-Platelet Ratio Index (APRI), FIB-4 score, and King score. Using the AUROC combines sensitivity and specificity across all possible cut-off values into a single statistical measure of diagnostic accuracy for predicting the presence and grade of esophageal varices. Esophagogastroduodenoscopy (EGD) will serve as the reference (gold standard) method for detecting and grading esophageal varices.
Baseline
Secondary Outcomes (1)
Correlation between non-invasive markers and endoscopic grade of esophageal varices in children with portal hypertension
Baseline
Eligibility Criteria
Portal hypertension in children will be defined using non-invasive clinical, laboratory, and Doppler-ultrasound criteria, in the context of clinical presentation, without invasive pressure measurements. Patients with portal hypertension will be classified as: patients with hepatic causes and patients with extrahepatic causes All patients included in this study will be subjected to: * 1\. Full Clinical History * 2\. Detailed Clinical Examination * 3\. Laboratory Investigations * 4\. Abdominal Ultrasound * 5\. Doppler Ultrasound * 6.Non-invasive predictive scores for esophageal varices The following parameters will be assessed: * Platelet count (PLT) * Spleen size z-score * Platelet count to spleen size ratio: * CPR (Calculated Platelet Ratio) * APRI (AST to Platelet Ratio Index) * FIB-4 * King score * MELD and PELD scores will be analyzed as secondary variables and not as primary predictors of esophageal varices -7. Esophagogastroduodenoscopy (EGD)
You may qualify if:
- Patients aged less than 18 years diagnosed with portal hypertension either due to hepatic or extrahepatic causes
You may not qualify if:
- Active variceal bleeding at presentation (hemodynamic instability affects platelet/spleen parameters).
- Previous history of variceal bleeding or endoscopic intervention (band ligation/sclerotherapy).
- Prior surgical portosystemic shunts or Transjugular Intrahepatic Portosystemic Shunt (TIPS).
- Current use of vasoactive drugs for primary prophylaxis (e.g., Non-selective beta-blockers).
- Systemic infections or hematological disorders causing independent thrombocytopenia or splenomegaly (to avoid confounding the platelet/spleen ratio).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer of Pediatrics
Study Record Dates
First Submitted
March 2, 2026
First Posted
March 11, 2026
Study Start
March 20, 2026
Primary Completion (Estimated)
March 20, 2028
Study Completion (Estimated)
May 20, 2028
Last Updated
March 23, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share